• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Dynavax Technologies (NQ: DVAX )

    11.79 +0.01 (+0.08%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Dynavax Technologies

    < Previous 1 2 3 4 5 6 Next >
    Uniqure Stock Sees Healthy Price Gain, Ranks Among Top 8%
    Among its other key ratings, Amsterdam-based gene therapy company Uniqure stock also has a 92 Composite Rating. 
    Via Investor's Business Daily
    Kezar Life Sciences Stock Shows Rising Market Leadership: Earns 81 RS Rating
    The Relative Strength (RS) Rating for Kezar Life Sciences stock jumped into a new percentile Friday, with a rise from 78 to 81. 
    Via Investor's Business Daily
    Apellis Pharmaceuticals Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
    Apellis Pharmaceuticals stock saw its Relative Strength (RS) Rating upgraded to 85 Friday, up from 79 a day earlier. 
    Via Investor's Business Daily
    7 Small-Cap Stocks to Buy in July 2022
    These are the best small-cap stocks to buy for July 2022. ARCH, AVUV, CEIX, COUR, DVAX, FATE, and TENB can make great investments. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Gainers 
    Via Benzinga
    Earnings Scheduled For February 28, 2022
    Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (... 
    Via Benzinga
    110 Biggest Movers From Friday
    Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital. 
    Via Benzinga
    56 Stocks Moving In Friday's Mid-Day Session
    Gainers Veru Inc. (NASDAQ: VERU) shares jumped 62.5% to $14.67 after the company reported quarterly results on Thursday. Jefferies maintained Veru with a Buy and raised the price target from $33 to... 
    Via Benzinga
    Dynavax's Adjuvant-Based Bivalent COVID-19 Vaccine Candidate Shows Encouraging Preclinical Action
    Via Benzinga
    Global Antibiotic Resistance Market to Hit US$16.5 Billion By 2030
    FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 21, 2022 – Resistance to antibiotics is a growing concern. About 750,000 people die each year worldwide from... 
    Via FinancialNewsMedia
    Dynavax Adjuvanted Clover Bio's COVID-19 Vaccine Booster Shows Durable Protection Against Omicron
    Via Benzinga
    The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    Recap: Dynavax Technologies Q4 Earnings
    Dynavax Technologies (NASDAQ:DVAX) reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement.... 
    Via Benzinga
    A Preview Of Dynavax Technologies's Earnings
    Dynavax Technologies (NASDAQ:DVAX) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to know before the announcement. Analysts... 
    Via Benzinga
    Three doses of Valneva's COVID-19 Vaccine Neutralizes Omicron Variant, Lab Study Shows
    Valneva SE (NASDAQ: VALN) has announced results from an initial laboratory study demonstrating that serum antibodies induced by three doses of Valneva's COVID-19 vaccine... 
    Via Benzinga
    10 Biggest Price Target Changes For Wednesday
    Tigress Financial lifted the price target on McDonald's Corporation (NYSE: 
    Via Benzinga
    Here's Why These 3 COVID-19 Vaccine Stocks Got Crushed This Week
    These second-tier COVID-19 vaccine players plunged due to fears about the potential impacts of the omicron variant. 
    Via The Motley Fool
    Exposures COVID-19
    Why Dynavax Stock Is Tumbling Today
    The biotech stock is being pulled down by the broader market sell-off. 
    Via The Motley Fool
    Why Are Valneva Shares Trading Higher Today?
    Valneva SE (NASDAQ: VALN) has signed an Advance Purchase Agreement (APA) with the European Commission (EC) to supply up to 60 million doses of its inactivated COVID... 
    Via Benzinga
    2 Top Stocks You Can Still Buy for Under $20 a Share
    These two stocks have more than doubled in 2021, but they still can be bought for under $20 per share. 
    Via The Motley Fool
    Valneva Shares Soar On Securing EU COVID-19 Vaccine Deal
    Valneva SE (NASDAQ: VALN) shares jumped more than 20% after winning approval from the European Commission for a deal. Over two years, the Company would supply up... 
    Via Benzinga
    Exposures COVID-19
    64 Stocks Moving In Friday's Mid-Day Session
    Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 198.4% to $14.92. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the middle of the... 
    Via Benzinga
    92 Biggest Movers From Friday
    Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares jumped 99.8% to close at $9.99 on Friday. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the... 
    Via Benzinga
    Why Dynavax Stock Is Falling Today
    Shares of the vaccine maker are down sharply despite a positive earnings report. 
    Via The Motley Fool
    Dynavax Technologies (DVAX) Q3 2021 Earnings Call Transcript
    DVAX earnings call for the period ending September 30, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    28 Stocks Moving in Friday's Pre-Market Session
    Gainers ReWalk Robotics Ltd. (NASDAQ: RWLK) rose 65.8% to $2.14 in pre-market trading after the company announced its ReBoot device has been granted designation as a Breakthrough... 
    Via Benzinga
    Will Valneva and Dynavax Score With Their Late-to-the-Party COVID Vaccine?
    There's still a sizable market opportunity, especially in developing nations. 
    Via The Motley Fool
    Exposures COVID-19
    Scientific Reports Revealing Early Promise for Universal Coronavirus Vaccine
    Palm Beach, FL – October 20, 2021 – FinancialNewsMedia.com News Commentary – Recently, scientific reports have shown that a universal coronavirus vaccine that protects against COVID-19 causing... 
    Via FinancialNewsMedia
    Exposures COVID-19
    Why Shares of Dynavax Technologies, Ocugen, and Valneva Are on the Move Today
    These COVID-19 vaccine developers are all moving in response to strong late-stage results for Valneva's VLA2001. 
    Via The Motley Fool
    Exposures COVID-19
    Why Are Valneva's Shares Trading Higher Monday Premarket?
    Valneva SE's (NASDAQ: VALN) COVID-19 vaccine elicits a robust immune response with far fewer side effects than the Oxford/AstraZeneca plc's (NASDAQ: AZN) jab,... 
    Via Benzinga
    Exposures COVID-19
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.